| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension |
| 01/01/2008 | US7314638 Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 12/27/2007 | WO2007149366A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 12/27/2007 | WO2007148774A1 Cyclic amine compound |
| 12/27/2007 | WO2007148720A1 Protein associated with nephrotic syndrome and use thereof |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 12/27/2007 | WO2007148494A1 Agent for increasing testosterone level |
| 12/27/2007 | WO2007147809A1 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy |
| 12/27/2007 | WO2007106708A3 Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril |
| 12/27/2007 | WO2007036543A8 Beta-3-agonist use for treating kidney and bladder troubles of a patient with spinal cord damages |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298108 Pharmaceutical Formulation |
| 12/27/2007 | US20070298097 Multi-carotenoids compositions and uses therefor |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298038 Compositions and methods for treating kidney disease |
| 12/27/2007 | US20070298030 Copper lowering treatment of inflammatory and fibrotic diseases |
| 12/27/2007 | US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3) |
| 12/27/2007 | CA2655016A1 Use of adenosine a1 antagonists in radiocontrast media induced nephrophaty |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 12/26/2007 | EP1870095A1 Composition for increasing anti-oxidation activity in blood |
| 12/26/2007 | EP1870093A1 Pharmaceutical combination comprising adenosine A1 receptor antagonists and radiocontrast media |
| 12/26/2007 | EP1401869B1 Molecules and methods for inhibiting shedding of kim-1 |
| 12/26/2007 | EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 12/26/2007 | CN101092442A Steroid compounds having contraceptive and anti-osteoporosis activity |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/26/2007 | CN101092405A Derivative of new benzothiadiazines, preparation method and usage |
| 12/26/2007 | CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors |
| 12/26/2007 | CN101091783A Preparation of Chinese traditional medicine for treating HIV infection, AIDS, tumours etc. multiple difficult diseases |
| 12/26/2007 | CN101091768A Composition of Chinese traditional medicine for lightening protein of urine |
| 12/26/2007 | CN101091764A Composition of Chinese traditional medicine for treating chronic nephritis |
| 12/26/2007 | CN101091749A Medicinal material of polygonum capilalum, extractive, and quality control method |
| 12/26/2007 | CN101091746A Oral liquid of specific dedicated medicine for treating acute and chronic nephritis |
| 12/26/2007 | CN101091726A Composition of health care composed of Cordyceps militaris and unsaturated oligosaccharide aldehydic acid |
| 12/26/2007 | CN101091718A Injection for preventing kidney disease caused by contrast agent |
| 12/26/2007 | CN101091705A Application of compounds in isorhodanic ester classes for treating diseases of prostate and skin cancer |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100356931C Method for supercritical fluid extraction of hyper plasia-resistant factor active matter in pumpkin seed |
| 12/26/2007 | CN100356913C R-bambuterol, its preparation and therapeutic uses |
| 12/26/2007 | CN100356871C Powder of amino acids and method for producing the same |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7311930 Herbal composition for treatment of chronic renal failure and method to produce thereof |
| 12/25/2007 | US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders |
| 12/21/2007 | WO2007145308A1 Agent for prevention and/or treatment of glomerulopathy |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007145192A1 Collagen type iv-like immunoreactive peptide |
| 12/21/2007 | WO2007144985A1 Use of rpn2 gene expression inhibitor |
| 12/21/2007 | WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use |
| 12/21/2007 | CA2655355A1 Use of rpn2 gene expression inhibitor |
| 12/21/2007 | CA2652133A1 Method for treating renal disease |
| 12/20/2007 | US20070293570 Pharmaceutical uses for alpha2delta ligands |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293553 Diphenylurea Derivatives Useful As Potassium Channel Activators |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293473 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| 12/20/2007 | US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 12/19/2007 | EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 12/19/2007 | EP1867343A2 Novel compounds |
| 12/19/2007 | EP1865770A2 The genetic risk assessment in heart failure: impact of the genetic variation of nos3 |
| 12/19/2007 | EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1295870B1 Suplatast tosilate crystals |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | EP1091757B1 Alpha emitting constructs and uses thereof |
| 12/19/2007 | EP1005341B1 Il-8 receptor antagonists |
| 12/19/2007 | EP0804440B1 Tricyclic benzazepine vasopressin antagonists |
| 12/19/2007 | CN101088519A Tripterygium glycosides extract and its extraction process |
| 12/19/2007 | CN101088510A Medicinal use of cordycepic polysaccharide |
| 12/19/2007 | CN101088404A Health food for invigrating kidney and its production process |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355744C Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355445C Medicine composition for treating chronic renal failure |
| 12/19/2007 | CN100355428C Preparation technology and use of Chinese herbal medicine phoenix-tail fern |
| 12/19/2007 | CN100355419C Therapeutic agent for overactive bladder |
| 12/19/2007 | CN100355415C Frozen dry powder injection of astrogalus root and its preparing method |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309713 Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome |